Sleep / Sleep Disorders / Cognitive Health / Cardiovascular Health

Sleep Apnea: The Hidden Epidemic Affecting Performance, Cognition, and Longevity

Creator: Dr. Joshua Lindsley
Published: 2026-03-29

Dr. Joshua Lindsley, DO | Last Updated: January 2026 | 19 min read

Key Takeaways

An estimated 83.7 million U.S. adults (32.4%) have obstructive sleep apnea, with approximately 80% of cases undiagnosed
Untreated sleep apnea raises dementia and Alzheimer’s disease risk by 28–43%, likely through impaired glymphatic clearance and intermittent hypoxia
Healthy, fit individuals can have significant sleep apnea—obesity is not required; anatomy, genetics, and alcohol use are key risk factors
CPAP remains the gold standard for moderate-to-severe OSA, but oral appliances and positional therapy are effective alternatives for milder cases
Subtle signs like morning headaches, teeth grinding, frequent nighttime urination, and afternoon fatigue often indicate undiagnosed sleep apnea

Summary

Sleep apnea is far more common and far more disruptive than most people realize. Yet, despite its prevalence, it often goes undiagnosed. An estimated 83.7 million U.S. adults (32.4%) have OSA, with prevalence rates of 39.1% in men and 26.0% in women.¹ Approximately 80% of cases remain undiagnosed, representing a major public health gap.²

The consequences of untreated sleep apnea extend far beyond daytime sleepiness—they include increased cardiovascular risk, accelerated cognitive decline, impaired performance, and a 28–43% elevated risk of dementia and Alzheimer’s disease.³ This brief covers why sleep apnea is so often missed, how nightly breathing disturbances affect the body, which treatments work, and how to optimize sleep quality whether or not you have apnea.

Key Concepts

What Is Sleep Apnea?

Term	Definition
Apnea	Complete cessation of breathing for ≥10 seconds
Hypopnea	Partial reduction in airflow (≥30%) with oxygen desaturation
AHI (Apnea-Hypopnea Index)	Number of apneas + hypopneas per hour of sleep
OSA (Obstructive Sleep Apnea)	Airway collapse causes breathing interruption
Central Sleep Apnea	Brain fails to signal breathing (less common)

Severity Classification

AHI Score	Severity	Clinical Significance
< 5	Normal	No clinical sleep apnea
5–15	Mild	May or may not need treatment
15–30	Moderate	Treatment generally recommended
> 30	Severe	Treatment strongly recommended

The Bottom Line

Sleep apnea is a highly prevalent condition that often goes undiagnosed, particularly in people who don’t fit the stereotypical profile. Even healthy, fit individuals can have significant sleep-disordered breathing that impairs their cognitive performance, cardiovascular health, and quality of life. The consequences extend beyond daytime sleepiness to include accelerated cognitive aging and potentially increased Alzheimer’s disease risk.

Recognition requires looking beyond obvious symptoms to subtle signs like morning headaches, frequent nighttime urination, difficulty concentrating, and persistent fatigue despite adequate time in bed. At-home sleep tests provide a reasonable screening option, though in-lab testing remains the gold standard for complex cases.

CPAP remains the most effective treatment for moderate-to-severe OSA, but alternatives including oral appliances and positional therapy can work for milder cases or CPAP-intolerant patients. Lifestyle factors—particularly weight management, alcohol avoidance, and sleep position—complement any treatment approach.

Treatment effectiveness should be monitored through both subjective improvements (energy, alertness, cognitive clarity) and objective measures (CPAP data, oximetry, or repeat testing). Given the profound impact of sleep quality on health and performance, identifying and treating sleep apnea represents a high-yield intervention for longevity and healthspan.

Continue Reading This Evidence-Based Guide

Free access to 235+ health education guides from Highland Longevity

No spam. Unsubscribe anytime.

Can Healthy People Have Sleep Apnea?

The Surprising Answer: Yes

Common misconceptions:

“I’m not overweight, so I can’t have sleep apnea”
“I’m young and athletic, it doesn’t apply to me”
“I don’t snore loudly, so it’s not an issue”

Risk Factors Beyond Obesity

Factor	How It Contributes
Anatomy	Small jaw, recessed chin, large tongue
Neck circumference	>17 inches (men), >16 inches (women)
Nasal obstruction	Deviated septum, allergies, polyps
Genetics	Family history increases risk
Age	Risk increases with age
Alcohol/sedatives	Relax airway muscles
Supine sleeping	Gravity collapses airway

Athletes and High Performers

Often have larger necks and airways that can collapse
High-intensity training can cause inflammation affecting airway
Performance may mask underlying fatigue
Frequently undiagnosed due to “healthy” appearance

Subtle Signs of Sleep Apnea

Beyond Obvious Snoring

Subtle Sign	What It May Indicate
Morning headaches	Overnight hypoxia, CO₂ retention
Dry mouth upon waking	Mouth breathing from obstruction
Night sweats	Autonomic arousal from apneas
Frequent nighttime urination	Atrial natriuretic peptide release
Teeth grinding (bruxism)	Airway protection reflex
Difficulty concentrating	Sleep fragmentation effects
Mood changes	Depression, irritability
Memory problems	Impaired consolidation

Signs Your Partner May Notice

Gasping or choking during sleep
Breathing pauses
Restless sleep
Loud snoring (though absence doesn’t rule out apnea)

High Performer Red Flags

Sign	Context
Afternoon fatigue despite good “sleep”	Sleep quality may be poor
Coffee dependence	Compensating for fragmented sleep
Performance plateau	Recovery impaired
Difficulty with sustained attention	Executive function compromised

Missed Sleep Apnea in High Performers

Why It’s Often Overlooked

Reason	Explanation
Successful compensation	Push through fatigue with caffeine, willpower
Attribution to lifestyle	Blame stress, workload, aging
Healthcare bias	Providers don’t suspect “healthy” patients
Lack of classic symptoms	May not snore loudly or be obese
Normalization	“Everyone is tired”

The Hidden Cost

Operating at 70–80% of potential capacity
Increased injury risk (particularly in athletes)
Accelerated cognitive aging
Cardiovascular strain
Shortened career/healthspan

How Much Nighttime Waking Is Normal?

Normal Sleep Architecture

Finding	Normal Range
Brief awakenings	2–5 per night is normal
Duration of awakenings	Should be <2–3 minutes
Awareness of waking	Often not remembered
Return to sleep	Should be quick and easy

When Waking Is Abnormal

Concern	What It May Indicate
Waking with heart racing	Possible apnea event
Waking choking/gasping	Airway obstruction
Waking to urinate >2x/night	Apnea-related (not just prostate)
Waking feeling unrested	Sleep fragmentation
Difficulty returning to sleep	May be after apnea arousal

Key Insight

Many people with sleep apnea don’t consciously wake—they experience “micro-arousals” that fragment sleep without awareness. The damage occurs whether you’re aware of waking or not.

Do At-Home Sleep Tests Work?

Types of Sleep Testing

Test Type	What It Measures	Pros	Cons
In-lab polysomnography (PSG)	Full sleep study with EEG, EMG, etc.	Gold standard	Expensive, inconvenient
Home sleep apnea test (HSAT)	Breathing, oxygen, sometimes heart rate	Convenient, affordable	May underestimate severity
Consumer wearables	Variable—often just oxygen, movement	Very accessible	Limited clinical validation

At-Home Test Accuracy

Consideration	Details
Sensitivity	Generally good for moderate-severe OSA
Specificity	May miss mild cases
False negatives	More common than in-lab
Best for	Screening, moderate-severe cases
Limitations	Doesn’t measure sleep stages, body position often

When In-Lab Testing Is Needed

Negative home test but high clinical suspicion
Complex sleep disorders suspected
Central sleep apnea possible
Treatment titration needed
Comorbid sleep disorders (narcolepsy, parasomnias)

Can Sleep Position Cause Apnea?

Positional Sleep Apnea

Position	Effect on Airway
Supine (back)	Gravity pulls tongue and soft tissue backward
Lateral (side)	Generally keeps airway more open
Prone (stomach)	Usually best for airway (but other concerns)

How Common Is Positional Apnea?

50–60% of OSA patients have worse apnea when supine⁴
Some have apnea only when supine (positional OSA)
May explain why sleep study results vary night to night

Positional Therapy

Method	How It Works
Tennis ball technique	Ball sewn into back of shirt prevents supine sleep
Positional pillows	Wedge or specialized pillows encourage side sleeping
Wearable devices	Vibrate when supine to prompt position change
Incline sleeping	Elevating head 30–45° reduces gravitational collapse

Effectiveness: Can reduce AHI by 50% or more in positional OSA

How Apnea Disrupts Sleep Architecture

Normal Sleep Cycles

Stage	Duration	Function
N1 (light)	5%	Transition
N2 (light)	45–55%	Memory consolidation, recovery
N3 (deep/slow-wave)	15–20%	Physical restoration, growth hormone
REM	20–25%	Memory consolidation, emotional processing

How Apnea Fragments Sleep

Event	Consequence
Apnea/hypopnea	Oxygen drops, CO₂ rises
Arousal	Brain wakes briefly to restore breathing
Sleep stage reset	Returns to lighter sleep
Repeat	Cycle prevents progression to deep/REM

Net Effect

Impact	Result
Reduced N3 (deep sleep)	Impaired physical recovery, reduced growth hormone
Reduced REM	Poor memory consolidation, emotional dysregulation
Fragmented sleep	Fatigue despite adequate time in bed
Chronic sleep debt	Accumulating cognitive and health effects

Why Do We Dream? (REM Sleep Function)

Functions of REM Sleep

Function	Explanation
Memory consolidation	Integrating new learning with existing knowledge
Emotional processing	Processing difficult experiences
Creativity	Novel associations between ideas
Brain housekeeping	Clearing metabolic waste

Apnea and REM Suppression

REM sleep occurs when muscle tone is lowest
Airway most collapsible during REM
Many people have worse apnea during REM
Results in selective REM sleep deprivation
May explain mood and memory effects of untreated apnea

Does Untreated Sleep Apnea Raise Alzheimer’s Risk?

The Evidence

Finding	Details
All-cause dementia risk	HR 1.33–1.43 (95% CI: 1.09–1.62) in meta-analyses³
Alzheimer’s disease risk	HR 1.28–1.45 (95% CI: 1.16–1.69) across studies³
Glymphatic clearance	Deep sleep clears brain waste; apnea disrupts this
Biomarker changes	OSA associated with lower CSF Aβ42 and higher tau/Aβ42 ratio³

Mechanisms of Harm

Pathway	Effect
Intermittent hypoxia	Oxidative stress, inflammation
Sleep fragmentation	Impaired glymphatic clearance
Cardiovascular effects	Vascular contributions to dementia
Chronic inflammation	Neuroinflammation

Clinical Implications

Screen for sleep apnea in patients with cognitive concerns
Treatment may be neuroprotective (evidence emerging)
Sleep optimization important for brain health at any age

Why Poor Sleep Wrecks Your Focus

Cognitive Effects of Sleep Apnea

Domain	Impact
Attention	Reduced sustained attention, easier distraction
Working memory	Harder to hold information in mind
Executive function	Impaired planning, decision-making
Reaction time	Slowed responses
Learning	Reduced acquisition of new information
Memory consolidation	Poor retention of learned material

Prefrontal Cortex Vulnerability

PFC particularly sensitive to sleep deprivation
Controls attention, impulse control, decision-making
First to suffer from fragmented sleep
Explains why apnea patients feel “foggy”

Comparison to Intoxication

Moderate sleep apnea cognitive effects comparable to legal intoxication
Driving impairment similar to 0.05–0.08% BAC
Yet people drive, operate machinery, make important decisions

Sleep as a Performance Enhancer

What Optimal Sleep Provides

Benefit	Mechanism
Physical recovery	Growth hormone release, tissue repair
Skill consolidation	Motor memory strengthened during sleep
Reaction time	Optimized neural processing
Decision making	Prefrontal cortex function restored
Injury prevention	Improved coordination, attention
Immune function	Enhanced recovery and resistance

Elite Performance and Sleep

Finding	Context
Extended sleep improves performance	Studies in basketball, tennis, other sports
Top athletes prioritize sleep	9–10+ hours common
Sleep extension improves metrics	Sprint times, accuracy, reaction time
Injury rates correlate with sleep	Less sleep = more injuries

The same principles apply to cognitive performance, productivity, and quality of life. Treating sleep apnea or optimizing sleep can unlock performance potential you didn’t know you were missing.

CPAP: The Gold Standard

How CPAP Works

Component	Function
Positive airway pressure	Pneumatic splint keeps airway open
Continuous delivery	Constant pressure throughout breathing cycle
Titration	Pressure adjusted to eliminate events

Benefits When Used Consistently

Benefit	Evidence Level
Reduced AHI	Very strong
Improved daytime alertness	Strong
Blood pressure reduction	~2 mmHg average; up to 4.8 mmHg in resistant hypertension⁵
Improved quality of life	Strong
Reduced cardiovascular events	Moderate (primarily in uncontrolled BP)⁵
Cognitive improvement	Moderate

Challenges

Issue	Solutions
Mask discomfort	Try different mask styles
Dry mouth/nose	Add humidification
Claustrophobia	Desensitization, nasal pillows
Noise	Modern machines very quiet
Travel inconvenience	Travel-sized machines available
Partner concerns	Quieter than snoring

CPAP Alternatives That Work

When CPAP Isn’t Tolerated

Alternative	How It Works	Best For
Mandibular advancement device (MAD)	Holds jaw forward to open airway	Mild-moderate OSA
Positional therapy	Prevents supine sleeping	Positional OSA
Weight loss	Reduces tissue around airway	Overweight patients
Surgery (various)	Removes or repositions tissue	Anatomical obstruction
Hypoglossal nerve stimulation	Electrical stimulation of tongue muscles	Moderate-severe, CPAP-intolerant

Oral Appliances (MADs)

Advantages:

More portable than CPAP
No electricity needed
Often better tolerated
Higher nightly adherence than CPAP in several studies⁶

Limitations:

Less effective for severe OSA
May cause jaw discomfort, TMJ issues
Requires dental fitting
Teeth may shift over time

Effectiveness: Typically 45–86% reduction in AHI depending on baseline severity; produces similar improvements in daytime sleepiness and quality of life compared to CPAP despite smaller AHI reductions⁶

Can Retainers Treat Sleep Apnea?

Mandibular Advancement Devices vs. Retainers

Device Type	Description
Custom MAD	Professional dental device, adjustable, fitted
Boil-and-bite MAD	OTC devices, one-size-fits-most
Standard retainer	Not designed for apnea; minimal advancement

Evidence for Oral Appliances

Finding	Details
Custom MADs effective	Reduce AHI 50–70%
Better compliance than CPAP	Many find more comfortable
Less effective for severe OSA	CPAP superior for AHI >30
Combination possible	MAD + positional therapy

Who’s a Good Candidate

Mild to moderate OSA
CPAP intolerant
No severe TMJ issues
Adequate dentition
Willing to follow up with dental provider

Mouth Taping: Sleep Hack or Hype?

The Claim

Taping mouth shut during sleep promotes nasal breathing, which some claim improves sleep quality and reduces apnea.

The Evidence

Aspect	Assessment
Nasal breathing benefits	Real—better filtration, humidification, nitric oxide
Impact on OSA	Limited evidence; may help mild cases
Safety concerns	Risk if nasal passages blocked
Quality evidence	Lacking—mostly anecdotal

Practical Considerations

Factor	Recommendation
Nasal obstruction	Must be able to breathe through nose
Existing sleep apnea	Don’t use as substitute for treatment
Mild snoring	May help some people
Try gradually	Don’t start with mouth fully sealed

Bottom Line on Mouth Taping

Not a treatment for sleep apnea. May complement other interventions for mild cases. Address nasal obstruction first. Not a substitute for proper diagnosis and treatment.

How to Know If Your Treatment Is Working

Subjective Markers

Improvement	What to Look For
Morning energy	Waking feeling refreshed
Daytime alertness	Reduced need for caffeine, no afternoon slump
Cognitive clarity	Better focus, memory, decision-making
Mood	Reduced irritability, depression
Partner report	Less snoring, gasping, restless sleep

Objective Markers

Measure	How to Assess
CPAP data	Modern machines track AHI, mask leak, usage
Overnight oximetry	Should show stable oxygen levels
Repeat sleep study	Confirms treatment effectiveness
Blood pressure	Often improves with effective treatment
Wearable data	Sleep stages, HRV may improve

Warning Signs Treatment Isn’t Working

Persistent daytime sleepiness despite compliance
Partner reports continued snoring/gasping
CPAP data shows high residual AHI
No improvement in objective measures

Action: Follow up with sleep provider for adjustment

Practical Protocol

If You Suspect Sleep Apnea

Self-assessment: Review subtle signs and risk factors
Partner input: Ask about snoring, gasping, breathing pauses
Screening questionnaire: STOP-BANG or Epworth Sleepiness Scale
Home sleep test: Reasonable first step for most
In-lab PSG: If home test negative but suspicion high

If Diagnosed

Severity	First-Line Treatment
Mild (AHI 5–15)	Lifestyle changes, positional therapy, consider MAD
Moderate (AHI 15–30)	CPAP or MAD
Severe (AHI >30)	CPAP strongly recommended

Lifestyle Optimization (All Severities)

Intervention	Expected Benefit
Weight loss (if overweight)	Can reduce AHI 30–50%+
Alcohol avoidance before bed	Reduces airway collapse
Sleep position	Side sleeping if positional apnea
Nasal breathing optimization	Treat allergies, consider strips
Sleep hygiene	Consistent schedule, dark/cool room

Key Studies & Data

Finding	Result	Significance
OSA prevalence (U.S. 2024)¹	83.7 million adults (32.4%); 39.1% men, 26.0% women	Far more common than historically estimated
Undiagnosed OSA²	~80% of cases undiagnosed	Major public health gap; $149.6B annual cost
OSA and dementia risk³	HR 1.33–1.43 for all-cause dementia	Potentially modifiable risk factor
OSA and Alzheimer’s³	HR 1.28–1.45 for Alzheimer’s disease	Sleep optimization may be neuroprotective
CPAP blood pressure⁵	~2 mmHg average; 4.8 mmHg in resistant HTN	Modest but clinically meaningful CV benefit
Oral appliances⁶	45–86% AHI reduction; similar QoL to CPAP	Higher adherence; viable for mild-moderate
Positional therapy⁴	50%+ AHI reduction in positional OSA	Simple, effective for appropriate patients

Additional Considerations

Study Limitations

Prevalence estimates: OSA prevalence data varies widely based on diagnostic criteria—2024 estimates suggest 32.4% of U.S. adults affected, substantially higher than older 20–25% estimates¹
Treatment studies: CPAP trials often have high dropout rates and variable compliance, making efficacy data difficult to interpret
Alzheimer’s association: Meta-analyses showing HR 1.28–1.45 for Alzheimer’s risk are observational and cannot establish causation; reverse causality (early dementia causing OSA) remains possible³

Conflicting Evidence

CPAP for cardiovascular prevention: Some large trials (SAVE trial) showed no cardiovascular benefit from CPAP in moderate-severe OSA patients already on optimal medical therapy.
Blood pressure reduction: CPAP effect on blood pressure is modest (2–3 mmHg) and not seen in all studies; may only benefit those with resistant hypertension.
Cognitive benefits: Mixed evidence on whether CPAP improves or prevents cognitive decline; some studies show benefit, others show no effect.

Individual Variation

Symptom presentation: Some people with severe OSA (AHI >30) are asymptomatic; others with mild OSA have significant symptoms.
Treatment response: Success with CPAP, oral appliances, and positional therapy varies dramatically between individuals.
Anatomical factors: Those with primarily anatomical obstruction may respond better to surgical options than those with neuromuscular causes.

Safety Notes

Driving risk: Untreated OSA significantly increases motor vehicle accident risk; treatment may be legally required in some jurisdictions for commercial drivers.
Perioperative risk: Untreated OSA increases surgical complication risk; disclose sleep apnea status to anesthesiologists.
Medication caution: Opioids, benzodiazepines, and sedatives can worsen OSA; use with extreme caution in diagnosed or suspected OSA.

Evidence Gaps

Long-term neurodegenerative outcomes: Whether treating OSA prevents Alzheimer’s disease remains unproven in randomized trials.
Optimal AHI target: What residual AHI level is acceptable during treatment not well established.
Prevention strategies: Whether weight loss or lifestyle changes in youth can prevent OSA development unclear.

Recent Developments

Revised prevalence estimates: 2024–2025 data suggest OSA affects 32.4% of U.S. adults (83.7 million), projected to reach 77 million by 2050¹
GLP-1 impact limited: Despite weight loss benefits, GLP-1 therapies estimated to reduce OSA prevalence by only 4% by 2050¹
Hypoglossal nerve stimulation: FDA-approved Inspire device showing promise for CPAP-intolerant patients with moderate-severe OSA
Blood pressure phenotyping: 2025 meta-analysis identifies uncontrolled BP at baseline as key predictor of CPAP benefit⁵
Position-sensing therapies: Wearable devices that vibrate when supine showing effectiveness for positional OSA

References

Benjafield AV, et al. Unmasking obstructive sleep apnea: Estimated prevalence and impact in the United States. Respiratory Medicine. 2025. DOI: 10.1016/j.rmed.2025.107411
Young T, et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20(9):705–706. Recent estimates confirm ~80% underdiagnosis rate.
Guay-Gagnon M, et al. Sleep apnea and the risk of dementia: A systematic review and meta-analysis. Journal of Sleep Research. 2022;31(5):e13589. DOI: 10.1111/jsr.13589. Updated 2025 meta-analysis confirms HR 1.34 for all-cause dementia.
Joosten SA, et al. Supine position related obstructive sleep apnea in adults: pathogenesis and treatment. Sleep Medicine Reviews. 2014;18(1):7–17. DOI: 10.1016/j.smrv.2013.01.005
Labarca G, et al. Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis. European Respiratory Journal. 2025;65(1):2400837. DOI: 10.1183/13993003.00837-2024
Schwartz M, et al. Mandibular advancement devices in obstructive sleep apnea: an updated review. Nature and Science of Sleep. 2022;14:357–373. DOI: 10.2147/NSS.S272745
McEvoy RD, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea (SAVE trial). New England Journal of Medicine. 2016;375(10):919–931. DOI: 10.1056/NEJMoa1606599

Medical Disclaimer: This educational brief is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any new health regimen. Individual results may vary. The information presented reflects current research as of January 2026 and may be updated as new evidence becomes available.